Reaffirms 2008 GAAP EPS Guidance Reflecting Growth of 27-29 Percent over
2007
First-Quarter Year-Over-Year Highlights (adjusted for January 2008
two-for-one stock split):
- GAAP diluted EPS increased 6.4 percent to $0.50 from $0.47 - Diluted EPS increased 5.8 percent to $0.55 from $0.52, excluding $0.05 in
amortization of intangible assets from the 2003 spin-off - Record net revenues of nearly $13.0 billion, an increase of 16.2 percent
from $11.2 billion
- Specialty revenues increased 30 percent to a record of nearly $1.9
billion from $1.4 billion - Record mail-order prescription volume of 26.6 million, up 3.2 million
prescriptions, or 13.7 percent from 23.4 million - Record-high generic dispensing rate of 63.3 percent, an increase of 5.1
percentage points from 58.2 percent
Reaffirms 2008 Guidance: - GAAP diluted EPS guidance of $2.07 to $2.11, reflects growth of 27 to 29
percent over 2007 - Diluted EPS guidance, excluding amortization of intangible assets, of
$2.27 to $2.31, reflects growth of 25 to 27 percent over 2007
FRANKLIN LAKES, N.J., April 29 /PRNewswire-FirstCall/ -- Driven by
record mail-order volume, generics performance, and a spectacular sales
year, Medco Health Solutions, Inc. (NYSE: MHS) today reported an increase
of 6.4 percent in first-quarter 2008 GAAP diluted earnings per share to
$0.50, compared to $0.47 for the first quarter of 2007. Excluding $0.05 per
share in amortization of intangible assets that existed when Medco became a
publicly traded com
'/>"/>
| SOURCE Medco Health Solutions, Inc. Copyright©2008 PR Newswire. All rights reserved |